Still Waiting

By ACSH Staff — Dec 15, 2009
An op-ed from FoodNavigator argues that BPA has become a litmus test for the FDA's leadership abilities: "Each day the U.S. Food and Drug Administration (FDA) dithers in delivering its verdict on the safety of bisphenol A (BPA) its authority is diminished and its credibility wanes."

An op-ed from FoodNavigator argues that BPA has become a litmus test for the FDA's leadership abilities: "Each day the U.S. Food and Drug Administration (FDA) dithers in delivering its verdict on the safety of bisphenol A (BPA) its authority is diminished and its credibility wanes."

"You may recall that the FDA pledged to release a statement about the safety of BPA in November," says ACSH's Dr. Elizabeth Whelan. "Well, November came and went, and there is still no statement. This is not a complicated topic, and it's not the first time an agency has been asked to rule on the safety of BPA. In fact, the FDA itself has ruled on BPA in years past, and they gave it a clean bill of health. It is puzzling that they are taking so long to rule on it again when it's such an obvious issue and so easy to come to a scientifically sound conclusion."

ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles